HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes.

Abstract
The regulation of insulin receptor (IR) tyrosine (tyr) phosphorylation is a key step in the control of insulin signaling. Augmented IR tyr dephosphorylation by protein tyrosine phosphatases (PTPs) may contribute to insulin resistance. To investigate this possibility in hyperglycemia-induced insulin resistance, primary cultured rat adipocytes were rendered insulin-resistant by chronic exposure (18 h) to 15 mmo/l glucose combined with 10(-7) mol/l insulin. Insulin-resistant adipocytes showed a decrease in insulin sensitivity and a maximum response of 2-deoxyglucose uptake, which was associated with a decrease in maximum insulin-stimulated IR tyr phosphorylation in situ. To assess tyr dephosphorylation, IRs of insulin-stimulated permeabilized adipocytes were labeled with [gamma-32P]ATP and chased for 2 min with unlabeled ATP in the presence of EDTA. In a nonradioactive protocol, insulin-stimulated adipocytes were permeabilized and exposed to EDTA and erbstatin for 2 min, and IRs were immunoblotted with anti-phosphotyrosine (pY) antibodies. Both methods showed a similar diminished extent of IR tyr dephosphorylation in resistant cells. Immunoblotting of four candidate IR-PTPs demonstrated no change in PTP1B or the SH2 domain containing phosphatase-2 (SHP-2), whereas a significant decrease in leukocyte antigen-related phosphatase (LAR) (51 +/- 3% of control) and an increase in PTP-alpha (165 +/- 16%) were found. Activity of immunoprecipitated PTPs toward a triple tyr phosphorylated IR peptide revealed a correlation with protein content for PTP1B, SHP-2, and LAR but a decrease in apparent specific activity of PTP-alpha. The data indicate that decreased IR tyr phosphorylation in hyperglycemia-induced insulin resistance is not due to enhanced dephosphorylation. The diminished IR tyr dephosphorylation observed in this model is associated with decreased LAR protein content and activity.
AuthorsS Tang, H Le-Tien, B J Goldstein, P Shin, R Lai, I G Fantus
JournalDiabetes (Diabetes) Vol. 50 Issue 1 Pg. 83-90 (Jan 2001) ISSN: 0012-1797 [Print] United States
PMID11147799 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphotyrosine
  • Tyrosine
  • Deoxyglucose
  • Receptor, Insulin
  • Protein Phosphatase 2
  • Protein Tyrosine Phosphatases
Topics
  • Adipocytes (metabolism)
  • Animals
  • Deoxyglucose (pharmacokinetics)
  • Hyperglycemia (metabolism, physiopathology)
  • Immunoblotting
  • Insulin Resistance (physiology)
  • Male
  • Phosphorylation (drug effects)
  • Phosphotyrosine (metabolism)
  • Protein Phosphatase 2
  • Protein Tyrosine Phosphatases (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Insulin (metabolism)
  • Tyrosine (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: